Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2022

Open Access 01-12-2022 | Osteoarthrosis | Research

Improving multimorbidity measurement using individualized disease-specific quality of life impact assessments: predictive validity of a new comorbidity index

Authors: Mindy L. McEntee, Barbara Gandek, John E. Ware

Published in: Health and Quality of Life Outcomes | Issue 1/2022

Login to get access

Abstract

Background

Interpretation of health-related quality of life (QOL) outcomes requires improved methods to control for the effects of multiple chronic conditions (MCC). This study systematically compared legacy and improved method effects of aggregating MCC on the accuracy of predictions of QOL outcomes.

Methods

Online surveys administered generic physical (PCS) and mental (MCS) QOL outcome measures, the Charlson Comorbidity Index (CCI), an expanded chronic condition checklist (CCC), and individualized QOL Disease-specific Impact Scale (QDIS) ratings in a developmental sample (N = 5490) of US adults. Controlling for sociodemographic variables, regression models compared 12- and 35-condition checklists, mortality vs. population QOL-weighting, and population vs. individualized QOL weighting methods. Analyses were cross-validated in an independent sample (N = 1220) representing the adult general population. Models compared estimates of variance explained (adjusted R2) and model fit (AIC) for generic PCS and MCS across aggregation methods at baseline and nine-month follow-up.

Results

In comparison with sociodemographic-only regression models (MCS R2 = 0.08, PCS = 0.09) and Charlson CCI models (MCS R2 = 0.12, PCS = 0.16), increased variance was accounted for using the 35-item CCC (MCS R2 = 0.22, PCS = 0.31), population MCS/PCS QOL weighting (R2 = 0.31–0.38, respectively) and individualized QDIS weighting (R2 = 0.33 & 0.42). Model R2 and fit were replicated upon cross-validation.

Conclusions

Physical and mental outcomes were more accurately predicted using an expanded MCC checklist, population QOL rather than mortality CCI weighting, and individualized rather than population QOL weighting for each reported condition. The 3-min combination of CCC and QDIS ratings (QDIS-MCC) warrant further testing for purposes of predicting and interpreting QOL outcomes affected by MCC.
Appendix
Available only for authorised users
Literature
1.
2.
Fortin M, Hudon C, Dubois M-F, Almirall J, Lapointe L, Soubhi H. Comparative assessment of three different indices of multimorbidity for studies on health-related quality of life. Health Qual Life Outcomes. 2005;3:1–7.CrossRef
3.
Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54:661–74.PubMedCrossRef
4.
Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B, Fratiglioni L. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10:430–9.PubMedCrossRef
5.
6.
Phyo AZZ, Freak-Poli R, Craig H, Gasevic D, Stocks NP, Gonzalez-Chica DA, Ryan J. Quality of life and mortality in the general population: a systematic review and meta-analysis. BMC Public Health. 2020;20:1–20.CrossRef
7.
Fisher KA, Griffith LE, Gruneir A, Upshur R, Perez R, Favotto L, Nguyen F, Markle-Reid M, Ploeg J. Effect of socio-demographic and health factors on the association between multimorbidity and acute care service use: Population-based survey linked to health administrative data. BMC Health Serv Res. 2021;21:1–17.CrossRef
8.
Fleishman JA, Cohen JW, Manning WG, Kosinski M. Using the SF-12 health status measure to improve predictions of medical expenditures. Med Care. 2006;44:I54–63.PubMedCrossRef
9.
Burgess R, Bishop A, Lewis M, Hill J. Models used for case-mix adjustment of patient reported outcome measures (PROMs) in musculoskeletal healthcare: a systematic review of the literature. Physiotherapy. 2019;105:137–46.PubMedCrossRef
10.
Feinstein AR. An additional basic science for clinical medicine: IV. The development of clinimetrics. Ann Intern Med. 1983;99:843–8.PubMedCrossRef
11.
Carrozzino D, Patierno C, Guidi J, Montiel CB, Cao J, Charlson ME, Christensen KS, Concato J, De las Cuevas C, De Leon J, Clinimetric criteria for patient-reported outcome measures. Psychother Psychosomat 2021;90:222–32.
12.
Tinetti ME, Studenski SA. Comparative effectiveness research and patients with multiple chronic conditions. N Engl J Med. 2011;364:2478–81.PubMedCrossRef
13.
Ahmed S, Berzon RA, Revicki DA, Lenderking WR, Moinpour CM, Basch E, Reeve BB, Wu AW. The use of patient-reported outcomes (PRO) within comparative effectiveness research: Implications for clinical practice and health care policy. Med Care. 2012;50:1060–70.PubMedCrossRef
14.
Maciejewski ML, Bayliss EA. Approaches to comparative effectiveness research in multimorbid populations. Med Care. 2014;52 Suppl 3:S23-30.PubMedCrossRef
15.
Franklin PD, Zheng H, Bond C, Lavallee DC: Translating clinical and patient-reported data to tailored shared decision reports with predictive analytics for knee and hip arthritis. Qual Life Res 2020:1–8.
16.
Rolfson O, Malchau H. The use of patient-reported outcomes after routine arthroplasty: beyond the whys and ifs. Bone Joint J. 2015;97-B:578–81.PubMedCrossRef
17.
Makovski TT, Schmitz S, Zeegers MP, Stranges S, van den Akker M. Multimorbidity and quality of life: systematic literature review and meta-analysis. Ageing Res Rev. 2019;53: 100903.PubMedCrossRef
18.
Bayliss EA, Bonds DE, Boyd CM, Davis MM, Finke B, Fox MH, Glasgow RE, Goodman RA, Heurtin-Roberts S, Lachenmayr S. Understanding the context of health for persons with multiple chronic conditions: moving from what is the matter to what matters. The Ann Fam Med. 2014;12:260–9.PubMedCrossRef
19.
Rojanasopondist P, Galea VP, Connelly JW, Matuszak SJ, Rolfson O, Bragdon CR, Malchau H. What preoperative factors are associated with not achieving a minimum clinically important difference after THA? Findings from an international multicenter study. Clin Orthop Relat Res. 2019;477:1301.PubMedPubMedCentralCrossRef
20.
Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622–9.PubMedCrossRef
21.
De Vet HC, Terwee CB, Bouter LM. Clinimetrics and psychometrics: two sides of the same coin. J Clin Epidemiol. 2003;56:1146–7.CrossRef
22.
Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom. 2022;91:8–35.PubMedCrossRef
23.
Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27:S217–32.PubMedCrossRef
24.
Ware JE Jr, Gandek B, Guyer R, Deng N. Standardizing disease-specific quality of life measures across multiple chronic conditions: development and initial evaluation of the QOL Disease Impact Scale (QDIS®). Health Qual Life Outcomes. 2016;14:84.PubMedPubMedCentralCrossRef
25.
Ware JE Jr, Harrington M, Guyer R, Boulanger R. A system for integrating generic and disease-specific patient-reported outcome (PRO) measures. Mapi Res Inst Patient Rep Outcomes Newslett. 2012;48:1–4.
26.
Ware JE Jr, Richardson MM, Meyer KB, Gandek B. Improving CKD-specific patient-reported measures of health-related quality of life. J Am Soc Nephrol. 2019;30:664–77.PubMedPubMedCentralCrossRef
27.
Ware JE Jr, Gandek B, Allison J. The validity of disease-specific quality of life attributions among adults with multiple chronic conditions. Int J Stat Med Res. 2016;5:17–40.PubMedPubMedCentralCrossRef
28.
Ware JE Jr, Guyer R. Validity of QOL impact attributions to specific diseases: a multitrait-multimethod comparison. Value Health. 2013;16:A599-600.CrossRef
29.
McDowell I. Measuring health: a guide to rating scales and questionnaires. USA: Oxford University Press; 2006.CrossRef
30.
De Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2003;56:221–9.PubMedCrossRef
31.
Manning Jr WG, Newhouse JP, Ware Jr JE, The status of health in demand estimation; or, beyond excellent, good, fair, poor. In: Economic aspects of health. University of Chicago Press; 1982: 141–184.
32.
Lash TL, Mor V, Wieland D, Ferrucci L, Satariano W, Silliman RA. Methodology, design, and analytic techniques to address measurement of comorbid disease. J Gerontol A Biol Sci Med Sci. 2007;62:281–5.PubMedCrossRef
33.
Brilleman SL, Gravelle H, Hollinghurst S, Purdy S, Salisbury C, Windmeijer F. Keep it simple? Predicting primary health care costs with clinical morbidity measures. J Health Econ. 2014;35:109–22.PubMedPubMedCentralCrossRef
34.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Clin Epidemiol. 1987;40:373–83.
35.
Elixhauser A, Steiner C, Harris DR, Coffey RM, Comorbidity measures for use with administrative data. Med care 1998;8–27.
36.
Bjorner JB, Kosinski M, Ware JE Jr. The feasibility of applying item response theory to measures of migraine impact: a re-analysis of three clinical studies. Qual Life Res. 2003;12:887–902.PubMedCrossRef
37.
Deng N, Anatchkova MD, Waring ME, Han KT, Ware JE Jr. Testing item response theory invariance of the standardized Quality-of-life Disease Impact Scale (QDIS®) in acute coronary syndrome patients: differential functioning of items and test. Qual Life Res. 2015;24:1809–22.PubMedCrossRef
38.
Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23:455–68.PubMedCrossRef
39.
Harrison C, Fortin M, van den Akker M, Mair F, Calderon-Larranaga A, Boland F, Wallace E, Jani B, Smith S. Comorbidity versus multimorbidity: why it matters. London, England: SAGE Publications Sage UK; 2021.
40.
Ware Jr JE, Guyer R, Harrington M, Strom M, Boulanger R: Evaluation of a more comprehensive survey item bank for standardizing disease-specific impact comparisons across chronic conditions. Qual Life Res. 2012; 27–8.
41.
Ware JE Jr, Kosinski M, Bjorner JB, Bayliss MS, Batenhorst A, Dahlöf CG, Tepper S, Dowson A. Applications of computerized adaptive testing (CAT) to the assessment of headache impact. Qual Life Res. 2003;12:935–52.PubMedCrossRef
42.
Goodman RA, Posner SF, Huang ES, Parekh AK, Koh HK. Measuring chronic conditions: imperatives for research, policy, program, and practice. Prev Chronic Dis. 2013;10:E66.PubMedPubMedCentral
43.
Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Care Res: Off J Am College Rheumatol. 2003;49:156–63.CrossRef
44.
Bayliss EA, Ellis JL, Steiner JF. Subjective assessments of comorbidity correlate with quality of life health outcomes: Initial validation of a comorbidity assessment instrument. Health Qual Life Outcomes. 2005;3:51.PubMedPubMedCentralCrossRef
45.
Poitras M-E, Fortin M, Hudon C, Haggerty J, Almirall J. Validation of the disease burden morbidity assessment by self-report in a French-speaking population. BMC Health Serv Res. 2012;12:1–6.CrossRef
46.
Byles JE, D’Este C, Parkinson L, O’Connell R, Treloar C. Single index of multimorbidity did not predict multiple outcomes. J Clin Epidemiol. 2005;58:997–1005.PubMedCrossRef
47.
Ware JE Jr, Kosinski M, Dewey JE, Gandek B. How to score and interpret single-item health status measures: a manual for users of the SF-8 health survey. Lincoln, RI: QualityMetric Incorporated. 2001;15:5.
48.
Ware Jr JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A, Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995:AS264–79.
49.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–83.PubMedCrossRef
50.
51.
Parsons VL, Design and estimation for the national health interview survey, 2006–2015. US Department of Health and Human Services, Centers for Disease Control and …; 2014.
52.
United States Department of Health and Human Services Center for Medicare and Medicaid Services: Medicare Health Outcomes Survey (HOS), 2016;1998–2014.
53.
Ware Jr JE, Kosinski M, Bjorner J, Turner-Bowker D, Gandek B, Maruish M,User's Manual for the SF-36v2 Health Survey. Lincoln, RI: QualityMetric Incorporated; 2007.
54.
Ware JE Jr, Bayliss MS, Rogers WH, Kosinski M, Tarlov AR. Differences in 4-year health outcomes for elderly and poor, chronically iII patients treated in HMO and fee-for-service systems: results from the Medical Outcomes Study. JAMA. 1996;276:1039–47.PubMedCrossRef
55.
Alonso J, Ferrer M, Gandek B, Ware JE, Aaronson NK, Mosconi P, Rasmussen NK, Bullinger M, Fukuhara S, Kaasa S. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res. 2004;13:283–98.PubMedCrossRef
56.
Sechrest L. Incremental validity. In: Jackson DN, Messick S, editors. Problems in human assessment. New York: McGraw-Hill; 1967. p. 368–71.
57.
Haynes SN, Lench HC. Incremental validity of new clinical assessment measures. Psychol Assess. 2003;15:456–66.PubMedCrossRef
58.
Chaudhry S, Jin L, Meltzer D, Use of a self-report-generated Charlson Comorbidity Index for predicting mortality. Med Care 2005;607–15.
59.
Zhang JX, Iwashyna TJ, Christakis NA, The performance of different lookback periods and sources of information for Charlson comorbidity adjustment in Medicare claims. Med Care 1999;1128–39.
60.
61.
Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19:716–23.CrossRef
62.
Burnham KP, Anderson DR, A practical information-theoretic approach. Model selection and multimodel inference, 2nd ed Springer, New York 2002, 2.
63.
Burnham KP, Anderson DR. Multimodel inference: understanding AIC and BIC in model selection. Sociol Methods Res. 2004;33:261–304.CrossRef
64.
Mehta HB, Sura SD, Adhikari D, Andersen CR, Williams SB, Senagore AJ, Kuo YF, Goodwin JS. Adapting the Elixhauser comorbidity index for cancer patients. Cancer. 2018;124:2018–25.PubMedCrossRef
65.
Rundell SD, Resnik L, Heagerty PJ, Kumar A, Jarvik JG. Comparing the performance of comorbidity indices in predicting functional status, health-related quality of life, and total health care use in older adults with back pain. J Orthop Sports Phys Ther. 2020;50:143–8.PubMedCrossRef
66.
Dominick KL, Dudley TK, Coffman CJ, Bosworth HB. Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis. Arthritis Care Res. 2005;53:666–72.CrossRef
67.
Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582–92.PubMed
68.
69.
Huntley AL, Johnson R, Purdy S, Valderas JM, Salisbury C. Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide. The Ann Family Med. 2012;10:134–41.CrossRef
70.
Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716–24.PubMedCrossRef
71.
Ware JE Jr. Conceptualization and measurement of health-related quality of life: comments on an evolving field. Arch Phys Med Rehabil. 2003;84:S43-51.PubMedCrossRef
72.
Fava GA, Belaise C. A discussion on the role of clinimetrics and the misleading effects of psychometric theory. J Clin Epidemiol. 2005;58:753–6.PubMedCrossRef
73.
Fava GA, Ruini C, Rafanelli C. Psychometric theory is an obstacle to the progress of clinical research. Psychother Psychosom. 2004;73:145–8.PubMedCrossRef
74.
Zyzanski SJ, Perloff E. Clinimetrics and psychometrics work hand in hand. Arch Intern Med. 1999;159:1811–7.CrossRef
75.
Streiner DL. Clinimetrics vs. psychometrics: an unnecessary distinction. J Clin Epidemiol. 2003;56:1142–5.PubMedCrossRef
76.
Gerteis J, Izrael D, Deitz D, LeRoy L, Ricciardi R, Miller T, Basu J, Multiple chronic conditions chartbook. AHRQ Publications No, Q14–0038. Rockville, MD: Agency for Healthcare Research and Quality 2014, 4:2014.
77.
Ward BW, Schiller JS, Peer reviewed: prevalence of multiple chronic conditions among US adults: estimates from the National Health Interview Survey, 2010. Preventing chronic disease 2013; 10.
78.
Ware Jr JE, Kosinski M, Turner-Bowker DM, Gandeck B, User's Manual for the SF-12v2TM Health Survey. Lincoln, RI: QualityMetric Incorporated 2007.
79.
Guerra SG, Berbiche D, Vasiliadis H-M. Measuring multimorbidity in older adults: comparing different data sources. BMC Geriatr. 2019;19:166.CrossRef
80.
Corser W, Sikorskii A, Olomu A, Stommel M, Proden C, Holmes-Rovner M. Concordance between comorbidity data from patient self-report interviews and medical record documentation. BMC Health Serv Res. 2008;8:1–9.CrossRef
81.
Olomu AB, Corser WD, Stommel M, Xie Y, Holmes-Rovner M. Do self-report and medical record comorbidity data predict longitudinal functional capacity and quality of life health outcomes similarly? BMC Health Serv Res. 2012;12:1–9.CrossRef
82.
van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ, A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 2009;626–33.
83.
Ware JE Jr, Gandek B, Franklin P, Lemay C. Cutting edge solutions to improving the efficiency of PRO measurement: from real-data simulations to pilot testing before and after total joint replacement in a national registry. Qual Life Res. 2015;24:60.
Metadata
Title
Improving multimorbidity measurement using individualized disease-specific quality of life impact assessments: predictive validity of a new comorbidity index
Authors
Mindy L. McEntee
Barbara Gandek
John E. Ware
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2022
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-022-02016-7

Other articles of this Issue 1/2022

Health and Quality of Life Outcomes 1/2022 Go to the issue

Research

Minimal clinically important difference for the Mandarin version of the Tinnitus Questionnaire determined via anchor-based and distribution-based methods

Research

Urinary incontinence in pregnant women and its impact on health-related quality of life

Research

Problems undermining the health-related quality of life of people living with HIV in Spain: a qualitative study to inform the development of a novel clinic screening tool

Research

Development of shortened HIV-related stigma scales for young people living with HIV and young people affected by HIV in India

Research

Adaptation and validation of the HIV Knowledge Questionnaire-18 for the general population of Indonesia

Study protocol

Development and validation of the health-related quality of life instrument for Chinese infertile couples: a mixed-methods study protocol